skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Coronary Disease - Drug Therapy remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cardiovascular drugs. 7/12. Nitrate derivatives
Cardiovascular drugs. 7/12. Nitrate derivatives
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiovascular drugs. 7/12. Nitrate derivatives

Berthou, Julie ; Limat, Samuel ; Woronoff-Lemsi, Marie-Christine

Soins; la revue de référence infirmière, 2004-11 (690), p.55 [Periódico revisado por pares]

France

Sem texto completo

Citações Citado por
2
Therapy with nitrate derivatives
Therapy with nitrate derivatives
Material Type:
Artigo 		Adicionar ao Meu Espaço

Therapy with nitrate derivatives

Kantelip, J P

Soins. Cardiologie, 1985-12 (34), p.9

France

Sem texto completo

Citações Citado por
3
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve

Bairey Merz, C Noel ; Handberg, Eileen M ; Shufelt, Chrisandra L ; Mehta, Puja K ; Minissian, Margo B ; Wei, Janet ; Thomson, Louise E J ; Berman, Daniel S ; Shaw, Leslee J ; Petersen, John W ; Brown, Garrett H ; Anderson, R David ; Shuster, Jonathan J ; Cook-Wiens, Galen ; Rogatko, André ; Pepine, Carl J

European heart journal, 2016-05, Vol.37 (19), p.1504-1513 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
4
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome : Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome : Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome : Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial

SCIRICA, Benjamin M ; MORROW, David A ; BRAUNWALD, Eugene ; HOD, Hanoch ; MURPHY, Sabina A ; BELARDINELLI, Luiz ; HEDGEPETH, Chester M ; MOLHOEK, Peter ; VERHEUGT, Freek W. A ; GERSH, Bernard J ; MCCABE, Carolyn H

Circulation (New York, N.Y.), 2007-10, Vol.116 (15), p.1647-1652 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
5
Efficacy and safety of Shugan Jieyu Decoction in the treatment of coronary heart disease complicated with depression
Efficacy and safety of Shugan Jieyu Decoction in the treatment of coronary heart disease complicated with depression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of Shugan Jieyu Decoction in the treatment of coronary heart disease complicated with depression

Li, Zhenzhen ; Zhang, Jianying ; Qiao, Mingqi ; Wang, Xiaojin ; Guo, Yinghui ; Wang, Haijun

Medicine (Baltimore), 2023-03, Vol.102 (11), p.e33176-e33176 [Periódico revisado por pares]

United States: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
6
Efficacy and safety of Xuefu Zhuyu Granules combined with western medicine in the treatment of angina pectoris of coronary heart disease: A study protocol of a randomized, double-blind, placebo-controlled clinical trial
Efficacy and safety of Xuefu Zhuyu Granules combined with western medicine in the treatment of angina pectoris of coronary heart disease: A study protocol of a randomized, double-blind, placebo-controlled clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of Xuefu Zhuyu Granules combined with western medicine in the treatment of angina pectoris of coronary heart disease: A study protocol of a randomized, double-blind, placebo-controlled clinical trial

Liu, Dong ; Zeng, Yunjie ; Liang, Peng ; Jiang, Yunlu ; An, Su ; Ren, Pengcheng

Medicine (Baltimore), 2022-10, Vol.101 (43), p.e31235 [Periódico revisado por pares]

United States: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
7
Effectiveness and safety of Tiaogan formula in the treatment of coronary heart disease: A protocol for systematic review and meta-analysis
Effectiveness and safety of Tiaogan formula in the treatment of coronary heart disease: A protocol for systematic review and meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness and safety of Tiaogan formula in the treatment of coronary heart disease: A protocol for systematic review and meta-analysis

Mingtai, Chen ; Guofu, Zhong ; Junteng, Chen ; Ling, Men ; Jienan, Luan ; Zhihao, Luo

Medicine (Baltimore), 2022-12, Vol.101 (50), p.e32237 [Periódico revisado por pares]

United States: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
8
Calcium, calcium antagonists and coronary insufficiency
Calcium, calcium antagonists and coronary insufficiency
Material Type:
magazinearticle 		Adicionar ao Meu Espaço

Calcium, calcium antagonists and coronary insufficiency

Lablanche, J M ; Bertrand, M E

La revue du praticien, 1988-11, Vol.38 (27), p.1971-1974

France

Texto completo disponível

Citações Citado por
9
Treatment of the intermediate syndrome
Treatment of the intermediate syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of the intermediate syndrome

Mady, C ; Macruz, R

Arquivos brasileiros de cardiologia, 1979-02, Vol.32 (2), p.71 [Periódico revisado por pares]

Brazil

Sem texto completo

Citações Citado por
10
Use of bunitrolol (Ko 1366) in the therapy of angina pectoris
Use of bunitrolol (Ko 1366) in the therapy of angina pectoris
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of bunitrolol (Ko 1366) in the therapy of angina pectoris

Maranhão, M F ; Rocha, S W ; Lopes, M ; Toledo, M T ; Furlan, L ; Hilú, Jr, M ; Pereira da Cunha, G

Arquivos brasileiros de cardiologia, 1978-04, Vol.31 (2), p.143-147 [Periódico revisado por pares]

Brazil

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (449)
  2. Revistas revisadas por pares (741)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.142)
  2. magazinearticle  (9)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1975  (250)
  2. 1975Até1986  (452)
  3. 1987Até1998  (331)
  4. 1999Até2011  (85)
  5. Após 2011  (35)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (540)
  2. Alemão  (252)
  3. Russo  (138)
  4. Italiano  (82)
  5. Francês  (61)
  6. Japonês  (40)
  7. Chinês  (31)
  8. Português  (6)
  9. Polonês  (6)
  10. Espanhol  (5)
  11. Dinamarquês  (5)
  12. Húngaro  (4)
  13. Tcheco  (3)
  14. Romeno  (3)
  15. Búlgaro  (3)
  16. Norueguês  (2)
  17. Ucraniano  (2)
  18. Finlandês  (2)
  19. Hebraico  (1)
  20. Croatian  (1)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.